Newsroom

Frost & Sullivan Applauds IRIS for Innovation in Diabetic Retinopathy Technology 3.3.16

By broadening exam access via seamless cloud-based technology, IRIS is enabling more physicians to identify patients at risk of blindness MOUNTAIN VIEW, Calif., Feb. 2, 2016 /PRNewswire/ -- Based on its recent analysis of the diabetic retinopathy market, Frost & Sullivan recognizes US-based...

Sherrick (Rick) Wassel Elected Chairman of the Board of the Florida Institute for the Commercialization of Public Research 2.3.16

GAINESVILLE and BOCA RATON, FL, Feb. 3, 2016 --The Florida Institute for the Commercialization of Public Research (Florida Institute) announced today that Rick Wassel has been elected chairman of the board of directors of the Florida Institute, effective January 1, 2016. The board is comprised of...

Florida Institute Funds Gainesville-based RAPiD Genomics 12.17.15

GAINESVILLE, Fla. and BOCA RATON, Fla., Dec. 17, 2015 --The Florida Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with RAPiD Genomics a Gainesville-based company with technology licensed from the University of...

Florida Institute Funds Orlando-based Intecrowd 12.14.15

GAINESVILLE and BOCA RATON, Fla., Dec. 14, 2015 -- The Florida Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with Intecrowd LLC an Orlando-based company with technology licensed from the University of Central Florida...

Florida Institute Funds St. Petersburg-based KynderMed 11.30.15

GAINESVILLE and BOCA RATON, Fla., Nov. 30, 2015 -- The Florida Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with KynderMed, a medical device start-up company with technology developed at Florida State University....

Share

Facebook icon
Twitter icon
LinkedIn icon
Pinterest icon
e-mail icon